SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001395064-24-000008
Filing Date
2024-01-25
Accepted
2024-01-25 06:13:10
Documents
1
Period of Report
2024-01-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1706181182.html 4  
1 FORM 4 wk-form4_1706181182.xml 4 3088
  Complete submission text file 0001395064-24-000008.txt   4807
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Reporting) CIK: 0001395064 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39094 | Film No.: 24558489
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Issuer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)